Reply to letter to the editor
- PMID: 36655744
- DOI: 10.1002/jmv.28502
Reply to letter to the editor
Comment on
-
A protocol of trial of ivermectin in COVID-19 treatment critically changed after its completion.J Med Virol. 2023 Feb;95(2):e28505. doi: 10.1002/jmv.28505. J Med Virol. 2023. PMID: 36655750 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources